-
The Indianapolis-based pharmaceutical company, Eli Lilly and Company, announced Wednesday it will lower the prices of its branded insulin by 70 percent and will introduce more price caps for its non-branded insulin.
-
Indiana economists forecast that shortages in the supply chain and workforce will continue in 2022. The annual Indiana University Kelley School of…
-
Today we learn about research on the effectiveness of depression screenings.We also talk to an education reporter from WFYI about absenteeism in Indiana…